2012
DOI: 10.1074/jbc.m112.387316
|View full text |Cite
|
Sign up to set email alerts
|

Euglycemic Agent-mediated Hypothalamic Transcriptomic Manipulation in the N171–82Q Model of Huntington Disease Is Related to Their Physiological Efficacy

Abstract: Background: Huntington disease (HD) involves neurological and metabolic pathologies. Results: Euglycemic therapeutics that affect hypothalamic transcription ameliorate multiple aspects of HD pathology. Conclusion: Hypothalamic targeting in HD may yield enhanced HD drug efficacy. Significance: Wider consideration of the metabolic aspects of neurological disorders may be important for drug design.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 54 publications
(75 reference statements)
0
23
0
Order By: Relevance
“…On the other hand, Huntington's disease (HD), an autosomal and dominantly inherited neurodegenerative disorder characterized by neurological and cognitive symptoms, is accompanied by severe weight loss and metabolic abnormalities [12,13]. Impaired mitochondrial and energy metabolism, and a consequent negative energy balance, may contribute to the enhanced oxidative damage in HD pathogenesis [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, Huntington's disease (HD), an autosomal and dominantly inherited neurodegenerative disorder characterized by neurological and cognitive symptoms, is accompanied by severe weight loss and metabolic abnormalities [12,13]. Impaired mitochondrial and energy metabolism, and a consequent negative energy balance, may contribute to the enhanced oxidative damage in HD pathogenesis [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…RNA isolation from three individual animals in each experimental group was carried out using a Qiagen RNeasy Mini Kit (Qiagen, Inc., Valencia, CA), as described previously (Gesty-Palmer et al, 2013). RNA conversion to cDNA and subsequent hybridization with Sentrix MouseRef-8 Expression BeadChips (Illumina, San Diego, CA) was performed as described previously (Chadwick et al, 2010;Martin et al, 2012a). Microarray data were analyzed using DIANE 6.0 (http://www.…”
Section: Methodsmentioning
confidence: 99%
“…We have previously identified the hypothalamus as one of the most important physiological loci for both aging and neurodegenerative activities (Chadwick et al, 2012; Martin et al, 2012b). In the current study, we employed hypothalamic gene transcriptomic data from wildtype mice, of both genders, across a broad age range (6, 12, 18 months) (Figure 2; Tables S2–S4 Female, Tables S5–S7 Male).…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, at the present time, with the creation of high-dimensionality data analyzers, such as Plurigon , Ggobi and Iris following the widespread implementation of mass data collection pipelines (genome/proteome-wide), we may soon see the generation of highly predictive and nuanced structure-activity-relationships (SAR) specifically modeled against pathophysiological scenarios. We have already pioneered this approach, in a considerably low-scale manner, for the discovery and whole-animal SAR analysis of palliative agents for Huntington's disease (Martin et al, 2012b). In this study we were able to predict whole-animal therapeutic efficacy (using multiple biomedical indices) from complementary pathophysiological-pharmacogenomic-pattern investigation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation